Dove

Manufacturer
Conopco Inc. d/b/a Unilever | Unilever Raeford HPCNA
Effective date
2013-01-16
Label type
HUMAN OTC DRUG LABEL
Version
1
Source
full-release
Hydrated at
2026-05-31 22:34:45

Label at a glance#

ProductDove Visibly Clear Cool Essentials Antiperspirant and Deodorant
Active ingredientAluminum Zirconium Tetrachlorohydrex GLY
Label structure12 sections

Label contents#

Full prescribing information#

OTC - ACTIVE INGREDIENT SECTION

Active Ingredient

Aluminum Zirconium Tetrachlorohydrex GLY (15.2%)

OTC - PURPOSE SECTION

Purpose
anti-perspirant

INDICATIONS & USAGE SECTION

Uses

reduces underarm wetness

24 hour protection

WARNINGS SECTION

Warnings
For External Use Only

OTC - DO NOT USE SECTION

Do not use on broken skin

OTC - ASK DOCTOR SECTION

Ask a doctor before use if you have kidney disease

OTC - STOP USE SECTION

Stop use if rash or irritation occurs

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children.  If swallowed, get medical help or contact a Poison Control Center right away

DOSAGE & ADMINISTRATION SECTION

Directions
apply to underarms only

INACTIVE INGREDIENT SECTION

Inactive ingredients
Isostearyl Alcohol, C12-15 Alkyl Benzoate, Water (Aqua), Glycine, Cyclopentasiloxane, Dibutyl Lauroyl Glutamide, Dibutyl Ethylhexanoyl Glutamide, Fragrance (Parfum), Cetyl PEG/PPG-10/1 Dimethicone

OTC - QUESTIONS SECTION

Questions? Call toll-free 1-800-761-DOVE

PDP

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Dove Visibly Clear Cool EssentialsDove Visibly Clear Cool Essentials

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
0ca1d589-929b-4b33-bc5b-1d84abdafa6aProduct name120150324
fc363c46-397b-4476-ac0f-70e43e8e4592Product name120150324

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
64942-1276-12020-01-31C16284748780-19d75b9d1-176d-f424-e053-dadaa90a57ceDove Visibly Clear Cool Essentials Antiperspirant deodorant

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
64942-1276-1DoveVisibly Clear Cool Essentials Antiperspirant and Deodorant74 g in 1 CONTAINERSTICK741

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
64942-1276DOVE VISIBLY CLEAR COOL ESSENTIALS ANTIPERSPIRANT AND DEODORANT (ALUMINUM ZIRCONIUM TETRACHLOROHYDREX GLY) STICK [CONOPCO INC. D/B/A UNILEVER]1Legacy NDC, 1 package rows20130228_c37ebf3d-166d-4e0b-a60e-d229a20160ac.zip

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIISPL versionUploaded
Aluminum Zirconium Tetrachlorohydrex GLYACTIVE INGREDIENT8O386558JE1
Aluminum Zirconium Tetrachlorohydrex GLYACTIVE MOIETY8O386558JE1
ALKYL (C12-15) BENZOATEINACTIVE INGREDIENTA9EJ3J61HQ1
CETYL PEG/PPG-10/1 DIMETHICONE (HLB 5)INACTIVE INGREDIENT035JKJ76MT1
CYCLOMETHICONE 5INACTIVE INGREDIENT0THT5PCI0R1
DIBUTYL ETHYLHEXANOYL GLUTAMIDEINACTIVE INGREDIENT0IAF2L30VS1
DIBUTYL LAUROYL GLUTAMIDEINACTIVE INGREDIENT3V7K3IA58X1
GLYCINEINACTIVE INGREDIENTTE7660XO1C1
ISOSTEARYL ALCOHOLINACTIVE INGREDIENTQ613OCQ44Y1
WATERINACTIVE INGREDIENT059QF0KO0R1

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 10 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
64942-127664942-1276-1

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 9 matching rows.

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 1 · 26 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredientIID ingredientUNIIDosage form / routePotencyMaximum daily exposureMatch
GLYCINEGLYCINETE7660XO1CCAPSULE / ORAL62 mgExact identifier — unii candidate
20 equally ranked IID candidates
CYCLOMETHICONE 5CYCLOMETHICONE 50THT5PCI0RAEROSOL, FOAM / TOPICAL144 mgExact identifier — unii candidate
3 equally ranked IID candidates
GLYCINEGLYCINETE7660XO1CTABLET, CHEWABLE / ORAL267 mgExact identifier — unii candidate
20 equally ranked IID candidates
GLYCINEGLYCINETE7660XO1CINJECTION, POWDER, FOR SOLUTION / INTRADERMAL0.5 mgExact identifier — unii candidate
20 equally ranked IID candidates
GLYCINEGLYCINETE7660XO1CINJECTION, POWDER, FOR SOLUTION / SUBCUTANEOUS0.5 mgExact identifier — unii candidate
20 equally ranked IID candidates
GLYCINEGLYCINETE7660XO1CTABLET / ORAL163.31 mgExact identifier — unii candidate
20 equally ranked IID candidates
ISOSTEARYL ALCOHOLISOSTEARYL ALCOHOLQ613OCQ44YOINTMENT / TOPICALNAExact identifier — unii candidate
3 equally ranked IID candidates
GLYCINEGLYCINETE7660XO1CPOWDER / RESPIRATORY (INHALATION)2 mgExact identifier — unii candidate
20 equally ranked IID candidates
GLYCINEGLYCINETE7660XO1CINJECTION / INTRAMUSCULAR68 mgExact identifier — unii candidate
20 equally ranked IID candidates
GLYCINEGLYCINETE7660XO1CINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS200 mgExact identifier — unii candidate
20 equally ranked IID candidates
GLYCINEGLYCINETE7660XO1CPOWDER, FOR SOLUTION / ORAL0.09 mgExact identifier — unii candidate
20 equally ranked IID candidates
GLYCINEGLYCINETE7660XO1CINJECTION / INTRAVENOUS200 mgExact identifier — unii candidate
20 equally ranked IID candidates
GLYCINEGLYCINETE7660XO1CTABLET, ORALLY DISINTEGRATING / ORAL60 mgExact identifier — unii candidate
20 equally ranked IID candidates
GLYCINEGLYCINETE7660XO1CCAPSULE, DELAYED RELEASE / ORAL50 mgExact identifier — unii candidate
20 equally ranked IID candidates
GLYCINEGLYCINETE7660XO1CPASTE, DENTIFRICE / DENTAL0.34 %w/wExact identifier — unii candidate
20 equally ranked IID candidates
ISOSTEARYL ALCOHOLISOSTEARYL ALCOHOLQ613OCQ44YCREAM / TOPICAL3 %w/wExact identifier — unii candidate
3 equally ranked IID candidates
GLYCINEGLYCINETE7660XO1CINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / SUBCUTANEOUS10 mgExact identifier — unii candidate
20 equally ranked IID candidates
GLYCINEGLYCINETE7660XO1CINJECTION, SOLUTION / INTRAVENOUS0.42 %w/vExact identifier — unii candidate
20 equally ranked IID candidates
GLYCINEGLYCINETE7660XO1CSOLUTION / ORAL50 mgExact identifier — unii candidate
20 equally ranked IID candidates
CYCLOMETHICONE 5CYCLOMETHICONE 50THT5PCI0RCREAM, AUGMENTED / TOPICAL260 mgExact identifier — unii candidate
3 equally ranked IID candidates
GLYCINEGLYCINETE7660XO1CPOWDER, FOR SUSPENSION / ORAL400 mgExact identifier — unii candidate
20 equally ranked IID candidates
GLYCINEGLYCINETE7660XO1CINJECTION, POWDER, FOR SOLUTION / INTRAMUSCULAR40 mgExact identifier — unii candidate
20 equally ranked IID candidates
GLYCINEGLYCINETE7660XO1CINJECTION, POWDER, FOR SOLUTION / INTRAVENOUS3.76 mgExact identifier — unii candidate
20 equally ranked IID candidates
CYCLOMETHICONE 5CYCLOMETHICONE 50THT5PCI0RAEROSOL / TOPICAL2.5 %w/wExact identifier — unii candidate
3 equally ranked IID candidates
GLYCINEGLYCINETE7660XO1CINJECTABLE, LIPOSOMAL / INTRAVENOUS0.38 %w/vExact identifier — unii candidate
20 equally ranked IID candidates
ISOSTEARYL ALCOHOLISOSTEARYL ALCOHOLQ613OCQ44YLOTION / TOPICAL100 mgExact identifier — unii candidate
3 equally ranked IID candidates

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
a67164b2-6adc-447d-80f6-89f263419093c37ebf3d-166d-4e0b-a60e-d229a20160ac2013-01-16WarningsExact identifier
spl id: a67164b2-6adc-447d-80f6-89f263419093
spl set id: c37ebf3d-166d-4e0b-a60e-d229a20160ac

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.